Compare TGTX & DDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGTX | DDS |
|---|---|---|
| Founded | 1993 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 8.2B |
| IPO Year | 2008 | 2012 |
| Metric | TGTX | DDS |
|---|---|---|
| Price | $49.93 | $638.24 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 3 |
| Target Price | $49.80 | ★ $519.67 |
| AVG Volume (30 Days) | ★ 2.3M | 109.2K |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 5.55% |
| EPS Growth | ★ 1746.67 | N/A |
| EPS | 0.17 | ★ 16.04 |
| Revenue | $2,785,000.00 | ★ $6,563,336,000.00 |
| Revenue This Year | $49.08 | $0.99 |
| Revenue Next Year | $26.69 | $1.09 |
| P/E Ratio | $293.53 | ★ $40.28 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.76 | $487.74 |
| 52 Week High | $59.30 | $741.98 |
| Indicator | TGTX | DDS |
|---|---|---|
| Relative Strength Index (RSI) | 44.73 | 70.42 |
| Support Level | $45.37 | $568.04 |
| Resistance Level | $58.08 | $677.99 |
| Average True Range (ATR) | 2.12 | 22.37 |
| MACD | -0.51 | 5.92 |
| Stochastic Oscillator | 38.04 | 93.84 |
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. It operates Dillard's stores, clearance centers, and an Internet store at dillards.com, offering a wide selection of merchandise, including fashion apparel for women, men, and children, accessories, cosmetics, home furnishings, and other consumer goods. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company also operates a general contracting construction company, which is involved in constructing and remodelling stores for Dillard's. It operates in two business segments: Retail Operations, which generates the maximum revenue, and Construction.